Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitro.
Varga A, Gyulavári P, Greff Z, Futosi K, Németh T, Simon-Szabó L, Kerekes K, Szántai-Kis C, Brauswetter D, Kokas M, Borbély G, Erdei A, Mócsai A, Kéri G, Vántus T. Varga A, et al. Among authors: brauswetter d. PLoS One. 2015 Apr 14;10(4):e0124234. doi: 10.1371/journal.pone.0124234. eCollection 2015. PLoS One. 2015. PMID: 25874616 Free PMC article.
Correction: Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro.
Varga A, Gyulavári P, Greff Z, Futosi K, Németh T, Simon-Szabó L, Kerekes K, Szántai-Kis C, Brauswetter D, Kokas M, Borbély G, Erdei A, Mócsai A, Kéri G, Vántus T. Varga A, et al. Among authors: brauswetter d. PLoS One. 2015 Dec 16;10(12):e0144792. doi: 10.1371/journal.pone.0144792. eCollection 2015. PLoS One. 2015. PMID: 26672602 Free PMC article. No abstract available.
Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers.
Brauswetter D, Gurbi B, Varga A, Várkondi E, Schwab R, Bánhegyi G, Fábián O, Kéri G, Vályi-Nagy I, Peták I. Brauswetter D, et al. PLoS One. 2017 Sep 28;12(9):e0185687. doi: 10.1371/journal.pone.0185687. eCollection 2017. PLoS One. 2017. PMID: 28957417 Free PMC article.
Discovery and optimization of novel benzothiophene-3-carboxamides as highly potent inhibitors of Aurora kinases A and B.
Gyulavári P, Szokol B, Szabadkai I, Brauswetter D, Bánhegyi P, Varga A, Markó P, Boros S, Illyés E, Szántai-Kis C, Krekó M, Czudor Z, Őrfi L. Gyulavári P, et al. Among authors: brauswetter d. Bioorg Med Chem Lett. 2018 Oct 15;28(19):3265-3270. doi: 10.1016/j.bmcl.2018.05.064. Epub 2018 Jun 1. Bioorg Med Chem Lett. 2018. PMID: 30143423
The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers-In Vitro Studies.
Gurbi B, Brauswetter D, Varga A, Gyulavári P, Pénzes K, Murányi J, Zámbó V, Birtalan E, Krenács T, Becker DL, Csala M, Vályi-Nagy I, Peták I, Dános K. Gurbi B, et al. Among authors: brauswetter d. Cancers (Basel). 2019 Nov 22;11(12):1848. doi: 10.3390/cancers11121848. Cancers (Basel). 2019. PMID: 31766723 Free PMC article.
MEK Is a Potential Indirect Target in Subtypes of Head and Neck Cancers.
Gurbi B, Brauswetter D, Pénzes K, Varga A, Krenács T, Dános K, Birtalan E, Tamás L, Csala M. Gurbi B, et al. Among authors: brauswetter d. Int J Mol Sci. 2023 Feb 1;24(3):2782. doi: 10.3390/ijms24032782. Int J Mol Sci. 2023. PMID: 36769112 Free PMC article.
Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement.
Schwab R, Petak I, Kollar M, Pinter F, Varkondi E, Kohanka A, Barti-Juhasz H, Schönleber J, Brauswetter D, Kopper L, Urban L. Schwab R, et al. Among authors: brauswetter d. Lung Cancer. 2014 Jan;83(1):109-11. doi: 10.1016/j.lungcan.2013.10.006. Epub 2013 Oct 19. Lung Cancer. 2014. PMID: 24192513
14 results